Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0130 Transporter Info | ||||
Gene Name | SLC1A2 | ||||
Transporter Name | Excitatory amino acid transporter 2 | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class 1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
ASCL1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC1A2 gene | [1] | ||||
TF Protein Name |
Achaete-scute homolog 1 | Transcription Factor Info | ||||
Tissue |
Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Achaete-scute homolog 1 (ASCL1) can directly bind to the SLC1A2 gene, which in turn affects the expression or function of the drug transporter Excitatory amino acid transporter 2. | |||||
MYCN |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Repression of SLC1A2 gene in astrocytoma condition | [2] | ||||
TF Protein Name |
N-myc proto-oncogene protein | Transcription Factor Info | ||||
Studied Phenotype |
Astrocytoma [ICD11: 2A00.0Y] | |||||
Tissue |
Brain | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Human astrocytoma cells (HTB-148) | |||||
Detailed Description |
N-myc proto-oncogene protein (MYCN) has been reported to repress the transcription of SLC1A2 gene in astrocytoma condition, which leads to a decreased expression of the drug transporter Excitatory amino acid transporter 2. | |||||
Class 2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
NR3C1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC1A2 gene in health condition | [3] | ||||
TF Protein Name |
Glucocorticoid receptor | Transcription Factor Info | ||||
Affected Drug/Substrate |
Glutamate | |||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Brain | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Rats astrocyte isolates | |||||
Detailed Description |
Glucocorticoid receptor (NR3C1) has been reported to activate the transcription of SLC1A2 gene in health condition, which leads to an increased expression of the drug transporter Excitatory amino acid transporter 2. | |||||
Class 2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
YY1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Repression of SLC1A2 gene in health condition | [4] | ||||
TF Protein Name |
Transcriptional repressor protein YY1 | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Brain | |||||
Related DT Changes |
down regulating | |||||
Experimental Material |
YY1-loxP homozygous mice astrocytes | |||||
Detailed Description |
Transcriptional repressor protein YY1 (YY1), influenced by the exogenous manganese chloride, has been reported to repress the transcription of SLC1A2 gene in health condition , which leads to a decreased expression of the drug transporter Excitatory amino acid transporter 2. | |||||
Class 3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
FOXA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC1A2 gene | [5] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-alpha | Transcription Factor Info | ||||
Tissue |
Breast; Embryo; Liver; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-alpha (FOXA1) can directly bind to the SLC1A2 gene, which in turn affects the expression or function of the drug transporter Excitatory amino acid transporter 2. | |||||
FOXA2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC1A2 gene | [6] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Tissue |
Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) can directly bind to the SLC1A2 gene, which in turn affects the expression or function of the drug transporter Excitatory amino acid transporter 2. | |||||
Class 6.1: Rel homology region factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
EBF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC1A2 gene | [7] | ||||
TF Protein Name |
Transcription factor COE1 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor COE1 (EBF1) can directly bind to the SLC1A2 gene, which in turn affects the expression or function of the drug transporter Excitatory amino acid transporter 2. | |||||
NFKB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC1A2 gene in astrocytoma condition | [2] | ||||
TF Protein Name |
Nuclear factor NF-kappa-B p105 subunit | Transcription Factor Info | ||||
Studied Phenotype |
Astrocytoma [ICD11: 2A00.0Y] | |||||
Tissue |
Brain | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human astrocytoma cells (HTB-148) | |||||
Detailed Description |
Nuclear factor NF-kappa-B p105 subunit (NFKB1) has been reported to activate the transcription of SLC1A2 gene in astrocytoma condition, which leads to an increased expression of the drug transporter Excitatory amino acid transporter 2. | |||||
RELA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC1A2 gene in astrocytoma condition | [2] | ||||
TF Protein Name |
Transcription factor p65 | Transcription Factor Info | ||||
Studied Phenotype |
Astrocytoma [ICD11: 2A00.0Y] | |||||
Tissue |
Brain | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human astrocytoma cells (HTB-148) | |||||
Detailed Description |
Transcription factor p65 (RELA) has been reported to activate the transcription of SLC1A2 gene in astrocytoma condition, which leads to an increased expression of the drug transporter Excitatory amino acid transporter 2. | |||||
Class 6.3: p53 domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
TP53 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC1A2 gene in atherosclerosis condition | [8] | ||||
TF Protein Name |
Cellular tumor antigen p53 | Transcription Factor Info | ||||
Studied Phenotype |
Atherosclerosis [ICD11: BD40] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human hepatoblastoma cells (HepG2) | |||||
Detailed Description |
Cellular tumor antigen p53 (TP53) has been reported to activate the transcription of SLC1A2 gene in atherosclerosis condition, which leads to an increased expression of the drug transporter Excitatory amino acid transporter 2. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.